Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

1143studies shown

Showing 13-24 of 1,143

Drug study icon

RecruitingNCT06947941

Safety and Efficacy of KarXT + KarX-EC for Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in Canada, ...

Location not clearly listed

SchizophreniaDrugFrom 55 Years to 90 Years

Countries: United States, Australia, Canada, ...
Sponsor: Bristol-Myers Squibb
Condition: Schizophrenia

Drug study icon

RecruitingNCT07424404

KarXT and KarX-EC for schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in France, ...

Location not clearly listed

SchizophreniaDrugFrom 5 Years to 17 Years

Countries: United States, Australia, France, ...
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition: Schizophrenia

Drug study icon

RecruitingNCT07196501

Maintenance Effect of NBI-1065845 for depression

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in Canada, ...

In Canada

DepressionDrugOver 18 Years

Countries: United States, Australia, Canada, ...
Sponsor: Neurocrine Biosciences
Condition: Depression

Other study type icon

RecruitingNCT07022925

A study to Investigate the Accuracy of a Wearable Device in Collecting Data Related to Perimenopausal Symptoms in Women

The registry lists this study as recruiting. Study locations are listed in Canada.

In Canada

DepressionObservationalFrom 35 Years to 55 Years

Countries: Canada
Sponsor: IdentifyHer Limited
Condition: Depression

Behavioral study icon

RecruitingNCT07292883

Accelerated dTMS Smoking Cessation

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

AddictionBehavioralOver 18 Years

Countries: Canada
Sponsor: Waypoint Centre for Mental Health Care
Condition: Addiction

Device study icon

RecruitingNCT07212465

Accelerated Neuromodulation of Anterior Cingulate Cortex for Depression

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

DepressionDeviceFrom 60 Years to 85 Years

Countries: Canada
Sponsor: Rotman Research Institute at Baycrest
Condition: Depression

Device study icon

RecruitingNCT07428460

Accelerated Neuromodulation Therapy for Negative Symptoms of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

SchizophreniaDeviceFrom 18 Years to 65 Years

Countries: Canada
Sponsor: Douglas Mental Health University Institute
Condition: Schizophrenia

Device study icon

RecruitingNCT06854367

Accelerated vs. Conventional Theta Burst Stimulation for Late-life Depression

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

DepressionDeviceOver 60 Years

Countries: Canada
Sponsor: Centre for Addiction and Mental Health
Condition: Depression

Behavioral study icon

RecruitingISRCTN58029217

Acceptability and exploratory effects of an occupational therapy intervention to improve recovery and return to work of workers with mental health disorders in primary care

The registry lists this study as recruiting. Study locations are listed in Canada.

In Canada

Mental healthOtherFrom 18 Years to 120 Years

Countries: Canada
Sponsor: Université de Montréal
Condition: Mental health

Drug study icon

RecruitingNCT06620276

ACT_for Addiction and Depression

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

Depression, AddictionDrugFrom 18 Years to 70 Years

Countries: Canada
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)
Condition: Depression, Addiction

Behavioral study icon

RecruitingNCT04857775

Adaptation and Testing of Web and Mobile Interface for the ATTACH™ Intervention

This summary needs review. Please check the official study record and contact the research team for details.

Remote / online

Addiction, DepressionBehavioral

Countries: Canada
Sponsor: University of Calgary
Condition: Addiction, Depression

Drug study icon

RecruitingNCT06218030

Adjunctive Treatment With L-methylfolate for Treatment-Resistant Generalized Anxiety Disorder: a Study

This summary needs review. Please check the official study record and contact the research team for details.

In Canada

AnxietyDrugFrom 18 Years to 65 Years

Countries: Canada
Sponsor: Queen's University
Condition: Anxiety

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.